Unfortunately, the tumor suppressor p53 is mutated in a considerable number of cancer patients, therefore BAX migration to mitochondria and p53-linked activation of downstream caspases (proteases responsible for the effective, controlled “dismantling” of the cells) is impaired. Here, BAX is linked to cancer.